TMCnet

Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty

Catalyst OrthoScience Inc. ("Catalyst"), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced U.S. Food and Drug ...
Morningstar

Catalyst OrthoScience Announces Leadership Transition: Miguel A. Ramirez, MD, Appointed Chief Medical Officer

Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced the appointment of Dr.
Healio

Catalyst OrthoScience receives FDA 510(k) clearance of proximal humerus fracture system

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Catalyst OrthoScience received FDA 510(k) clearance of ...
Business Wire

Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer

NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D. as chief strategy ...
Business Wire

Catalyst OrthoScience Announces First Series of Procedures Using World’s Only Fully Convertible Stemmed CSR TSA System Featuring an Ellipsoid Humeral Head

NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has announced that internationally recognized ...
Morningstar

Catalyst OrthoScience Receives FDA 510(k) Clearance for Expanded Indications of the Fracture Shoulder System

New indications expand applications for Catalyst Fracture System to anatomic shoulder restorations Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder ...
Becker's Hospital Review

Catalyst OrthoSciences receives $15M investment

Medtech company Catalyst OrthoScience has received $15 million in equity and debt financing. The additional funding allows Catalyst to strengthen its balance sheet and advance its commercial and ...
BioWorld

Regulatory actions for Dec. 4, 2025

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Axogen, Catalyst Orthoscience, Insulet, MED-EL, Medtronic, ...
Law

New Suit - Patent

Catalyst Orthoscience was hit with a patent infringement lawsuit on Feb. 28 in Delaware District Court over its sale of the Archer-brand reverse shoulder system for implant placement. The court case ...
MedTech Intelligence

Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty

New patient-specific solution expands Catalyst’s portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy.

Catalyst OrthoScience Inc.: Catalyst OrthoScience Announces FDA 510(k) Clearance of Archer Patient-Specific Instrumentation for Shoulder Arthroplasty

New patient-specific solution expands Catalyst's portfolio, enabling precise translation of 3D surgical plans into the operating room to reduce steps and increase accuracy Catalyst OrthoScience ...